Disease | neutropenia |
Phenotype | C0019829|hodgkin lymphoma |
Sentences | 3 |
PubMedID- 22972488 | Primary prophylaxis with granulocyte colony-stimulating factor (gcsf) reduces the incidence of febrile neutropenia in patients with non-hodgkin lymphoma (nhl) receiving chop chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis. |
PubMedID- 24684228 | History of chronic comorbidity and risk of chemotherapy-induced febrile neutropenia in patients with non-hodgkin lymphoma not receiving granulocyte colony-stimulating factor prophylaxis. |
PubMedID- 23452152 | External validation of a risk model of febrile neutropenia occurrence in patients with non-hodgkin lymphoma. |
Page: 1